Solid ivabradine-containing composition

A solid composition containing ivabradine or a pharmaceutically acceptable salt thereof as active substance in combination with at least one pharmaceutically acceptable excipient characterized in that the excipient and the active substance are present in a homogeneous, molecularly disperse mixture, wherein the pharmaceutically acceptable excipient is selected from the group consisting of sucrose, sorbitol, xylitol, polyethylene glycol, polyoxyethylene glycol monosterate, glycerol polyethylene glycol ricinolate, macrogol glycerol stearate, glycerol palmitol stearate, macrogol glycerol laurate, polyethylene glycol cetylstearyl ether, glycerol monostearate, polyvinylpyrrolidone, cellulose derivatives, copovidone, and ethylene oxide-propylene oxide block-copolymers.